Unknown

Dataset Information

0

Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq.


ABSTRACT: High-grade meningioma has an unsatisfactory outcome despite surgery and postoperative radiotherapy; however, the factors driving its malignancy and recurrence remain largely unknown, which limits the development of systemic treatments. Single-cell RNA sequencing (scRNA-Seq) technology is a powerful tool for studying intratumoral cellular heterogeneity and revealing the roles of various cell types in oncogenesis. In this study, scRNA-Seq is used to identify a unique initiating cell subpopulation (SULT1E1+ ) in high-grade meningiomas. This subpopulation modulates the polarization of M2-type macrophages and promotes meningioma progression and recurrence. A novel patient-derived meningioma organoid (MO) model is established to characterize this unique subpopulation. The resulting MOs fully retain the aggressiveness of SULT1E1+ and exhibit invasiveness in the brain after orthotopic transplantation. By targeting SULT1E1+ in MOs, the synthetic compound SRT1720 is identified as a potential agent for systemic treatment and radiation sensitization. These findings shed light on the mechanism underlying the malignancy of high-grade meningiomas and provide a novel therapeutic target for refractory high-grade meningioma.

SUBMITTER: Huang M 

PROVIDER: S-EPMC10214266 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel Human Meningioma Organoids Recapitulate the Aggressiveness of the Initiating Cell Subpopulations Identified by ScRNA-Seq.

Huang Meng M   Xu Shao S   Li Yuzhe Y   Shang Li L   Zhan Xiudan X   Qin Chaoyin C   Su Jun J   Zhao Zijin Z   He Yi Y   Qin Lina L   Zhao Wei W   Long Wenyong W   Liu Qing Q  

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 20230330 15


High-grade meningioma has an unsatisfactory outcome despite surgery and postoperative radiotherapy; however, the factors driving its malignancy and recurrence remain largely unknown, which limits the development of systemic treatments. Single-cell RNA sequencing (scRNA-Seq) technology is a powerful tool for studying intratumoral cellular heterogeneity and revealing the roles of various cell types in oncogenesis. In this study, scRNA-Seq is used to identify a unique initiating cell subpopulation  ...[more]

Similar Datasets

| S-BSST858 | biostudies-other
| S-EPMC8179149 | biostudies-literature
| S-EPMC10354926 | biostudies-literature
| S-EPMC11593927 | biostudies-literature
| S-EPMC11009691 | biostudies-literature
| S-EPMC10933018 | biostudies-literature
| S-EPMC11436782 | biostudies-literature
| S-EPMC9007916 | biostudies-literature
| S-EPMC11336893 | biostudies-literature
| S-EPMC5825235 | biostudies-literature